NeuBase Therapeutics, Inc. Common Stock
NBSE
NBSE was delisted on the 10th of May, 2024.
66 hedge funds and large institutions have $15.3M invested in NeuBase Therapeutics, Inc. Common Stock in 2015 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 14 increasing their positions, 20 reducing their positions, and 14 closing their positions.
14% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 14
3% more funds holding
Funds holding: 64 → 66 (+2)
17% less capital invested
Capital invested by funds: $18.4M → $15.3M (-$3.15M)
30% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 20
90% less call options, than puts
Call options by funds: $40K | Put options by funds: $397K
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
NFA
76
Nationwide Fund Advisors
Columbus,
Ohio
| – | -$39K | -38 | Closed |
|
|
BA
77
BlackRock Advisors
Wilmington,
Delaware
| – | -$25K | -24 | Closed |
|
|
MFS
78
MSI Financial Services
Springfield,
Massachusetts
| – | -$13K | -13 | Closed |
|
79
BNP Paribas Financial Markets
Paris,
France
| – | -$2.65K | -3 | Closed |
|
80
Simplex Trading
Chicago,
Illinois
| – | -$1.08K | -1 | Closed |
|
NBSE Hedge Fund Activity: Q2 2015 in Review
66 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in NeuBase Therapeutics, Inc. Common Stock (NBSE) for Q2 2015, worth a combined $15.3M — down 17% from $18.4M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new NBSE positions and 14 closed out — a net gain of 2 holders — while 14 added to existing stakes and 20 trimmed.
The largest buyer was Turner Investments, adding an estimated $671K. The largest seller was BlackRock Fund Advisors, cutting an estimated $1.44M.
- 66 institutional investors held NeuBase Therapeutics, Inc. Common Stock (NBSE) as of Q2 2015, up from 64 in Q1 2015.
- Funds reported $15.3M of NeuBase Therapeutics, Inc. Common Stock stock for Q2 2015, down 17% quarter-over-quarter.
- 16 funds opened new NeuBase Therapeutics, Inc. Common Stock positions in Q2 2015 and 14 closed out, a net change of +2 holders.
- The largest NeuBase Therapeutics, Inc. Common Stock buyer in Q2 2015 was Turner Investments, an estimated $671K added.
- The largest NeuBase Therapeutics, Inc. Common Stock seller in Q2 2015 was BlackRock Fund Advisors, an estimated $1.44M sold.
Based on aggregated 13F filings for Q2 2015.